Few data are available on the effect of previous benign breast surgery on screening mammography accuracy. We determined whether sensitivity of screening mammography and tumor characteristics are different for women with and without previous benign breast surgery. We included a consecutive series of 317,398 screening mammograms of women screened between 1997 and 2008. During 2-year follow-up, clinical data, breast imaging, biopsy and surgery reports were collected from women with screen-detected or interval breast cancers. Screening sensitivity, tumor biology and tumor stages were compared between 168 women with breast cancer and prior ipsilateral benign breast surgery and 2,039 women with breast cancer but without previous ipsilateral, benign breast surgery. The sensitivity of screening mammography was significantly lower for women with prior surgery [64.3% (108/168) versus 73.4% (1,496/2,039), p 5 0.01]. The concomitant increased interval cancer risk remained significant after logistic regression adjustment for age and breast density (OR 5 1.5, 95% CI: 1.1-2.1). Comparing screen-detected cancers in women with and without prior breast surgery, no significant differences in estrogen receptor status (p 5 0.56), mitotic activity (p 5 0.17), proportions of large (T21) tumors (p 5 0.6) or lymph node positive tumors (p 5 0.4) were found. Also for interval cancers, no differences were found in estrogen receptor status (p 5 0.41), mitotic activity (p 5 0.39), proportions of large tumors (p 5 0.9) and lymph node positive tumors (p 5 0.5) between women with and without prior breast surgery. We conclude that sensitivity of screening mammography is significantly lower in women with previous benign breast surgery than without, but tumor characteristics are comparable both for screen detected cancers and interval cancers.Mammography screening aims to detect breast cancer at an early stage and several studies have shown that screening significantly reduces breast cancer mortality.1-3 Many countries have introduced regional or nationwide breast cancer screening programs in the last two decades. The Netherlands has a long history of screening mammography and their nationwide breast cancer screening program offers biennial screening mammography for women aged 50-75 years.Breast conserving treatment for breast cancer may cause rigorous mammographic changes, due to surgery and radiation therapy. [4][5][6] These changes frequently hamper the mammographic interpretation and may result in a lower sensitivity of mammography for breast cancer detection. On the other hand, post-treatment changes may simulate breast cancer at mammography and lead to an increase of false positive assessments and thus a lower specificity. The Dutch guidelines on breast cancer screening advise that mammographic follow-up for women after breast conserving therapy should take place in an outpatient hospital setting for a period of 5-10 years before returning to routine screening.
7Mammographic alterations occurring after breast surgery for benign disease and r...